We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$78.8B
AUM Growth
+$7.07B
Cap. Flow
+$2.22B
Cap. Flow %
2.81%
Top 10 Hldgs %
22%
Holding
3,838
New
237
Increased
1,800
Reduced
1,491
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Financials 9.56%
3 Healthcare 8.56%
4 Industrials 6.35%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBBX
2651
DELISTED
SB One Bancorp Common Stock
SBBX
$538K ﹤0.01%
21,572
+44
+0.2% +$1.02K
EUFN icon
2652
iShares MSCI Europe Financials ETF
EUFN
$4.28B
$536K ﹤0.01%
27,513
+11,917
+76% +$221K
KRTX
2653
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$536K ﹤0.01%
+7,110
New +$311K
CSB icon
2654
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$266M
$535K ﹤0.01%
11,374
+2,028
+22% +$92.8K
ONEQ icon
2655
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.8B
$535K ﹤0.01%
15,320
+280
+2% +$9.29K
THRM icon
2656
Gentherm
THRM
$1.25B
$534K ﹤0.01%
12,021
+1,076
+10% +$45.8K
BGIO
2657
DELISTED
BlackRock 2022 Global Income Opportunity Trust
BGIO
$534K ﹤0.01%
54,150
-20,107
-27% -$193K
EQT icon
2658
EQT Corp
EQT
$33.7B
$533K ﹤0.01%
48,919
-15,409
-24% -$151K
PBE icon
2659
Invesco Biotechnology & Genome ETF
PBE
$358M
$533K ﹤0.01%
9,541
-7,014
-42% -$366K
ARNA
2660
DELISTED
Arena Pharmaceuticals Inc
ARNA
$533K ﹤0.01%
11,735
-4,048
-26% -$191K
ALGT icon
2661
Allegiant Air
ALGT
$2.33B
$532K ﹤0.01%
3,054
+707
+30% +$117K
FTLS icon
2662
First Trust Long/Short Equity ETF
FTLS
$2.49B
$532K ﹤0.01%
12,461
-112
-0.9% -$4.68K
LOB icon
2663
Live Oak Bancshares
LOB
$1.97B
$532K ﹤0.01%
27,975
+5,684
+25% +$105K
PTEU icon
2664
Pacer Trendpilot European Index ETF
PTEU
$38.3M
$532K ﹤0.01%
19,366
+124
+0.6% +$3.38K
GEO icon
2665
The GEO Group
GEO
$4.1B
$530K ﹤0.01%
31,899
-16,922
-35% -$257K
BCRH
2666
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$530K ﹤0.01%
77,306
NHS
2667
Neuberger High Yield Strategies Fund Inc
NHS
$255M
$528K ﹤0.01%
42,771
-7,382
-15% -$88.8K
CGEN icon
2668
Compugen
CGEN
$229M
$527K ﹤0.01%
88,481
-1,131
-1% -$5.82K
SFL icon
2669
SFL Corp
SFL
$1.55B
$527K ﹤0.01%
36,242
+648
+2% +$9.37K
FCEF icon
2670
First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF
FCEF
$82.4M
$526K ﹤0.01%
22,910
+450
+2% +$10.1K
FIVN icon
2671
FIVE9
FIVN
$2.32B
$526K ﹤0.01%
8,016
+1,272
+19% +$77.8K
HPI
2672
John Hancock Preferred Income Fund
HPI
$435M
$526K ﹤0.01%
23,070
-832
-3% -$18.8K
HYEM icon
2673
VanEck Emerging Markets High Yield Bond ETF
HYEM
$526M
$526K ﹤0.01%
22,156
-19
-0.1% -$445
IPFF
2674
DELISTED
iShares International Preferred Stock ETF
IPFF
$526K ﹤0.01%
34,038
-5,457
-14% -$81.7K
EWU icon
2675
iShares MSCI United Kingdom ETF
EWU
$4.13B
$525K ﹤0.01%
15,401
+2,362
+18% +$76.8K

Similar funds

Raymond James & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Raymond James & Associates held 3,838 positions worth $78.8B, up 9.9% from $71.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q4 2019 filing shows 237 new, 1,800 increased, 1,491 reduced and 179 closed positions. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2019 buy was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M.
  • Raymond James & Associates added most to Vanguard High Dividend Yield ETF in Q4 2019, an estimated $672M increase.
  • Raymond James & Associates's biggest Q4 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $325M.
  • Raymond James & Associates fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $45.9M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $78.8B portfolio in Q4 2019.
  • Raymond James & Associates opened 237 new positions and closed 179 in Q4 2019.
  • Raymond James & Associates's portfolio value rose 9.9% quarter-over-quarter to $78.8B.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.